207 related articles for article (PubMed ID: 37164186)
1. Syphilis mimetic nanoparticles for cuproptosis-based synergistic cancer therapy via reprogramming copper metabolism.
Zhang J; Han M; Zhang J; Abdalla M; Sun P; Yang Z; Zhang C; Liu Y; Chen C; Jiang X
Int J Pharm; 2023 Jun; 640():123025. PubMed ID: 37164186
[TBL] [Abstract][Full Text] [Related]
2. An Enzyme-Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis-Based Synergistic Cancer Therapy.
Xu Y; Liu SY; Zeng L; Ma H; Zhang Y; Yang H; Liu Y; Fang S; Zhao J; Xu Y; Ashby CR; He Y; Dai Z; Pan Y
Adv Mater; 2022 Oct; 34(43):e2204733. PubMed ID: 36054475
[TBL] [Abstract][Full Text] [Related]
3. Photoinduced Cuproptosis with Tumor-Specific for Metastasis-Inhibited Cancer Therapy.
Zheng J; Ge H; Guo M; Zhang T; Hu Q; Yao Q; Long S; Sun W; Fan J; Du J; Peng X
Small; 2024 Mar; 20(10):e2304407. PubMed ID: 37880907
[TBL] [Abstract][Full Text] [Related]
4. Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD-L1 for Enhanced Cancer Immunotherapy.
Guo B; Yang F; Zhang L; Zhao Q; Wang W; Yin L; Chen D; Wang M; Han S; Xiao H; Xing N
Adv Mater; 2023 Jun; 35(22):e2212267. PubMed ID: 36916030
[TBL] [Abstract][Full Text] [Related]
5. Type-I AIE Photosensitizer Loaded Biomimetic System Boosting Cuproptosis to Inhibit Breast Cancer Metastasis and Rechallenge.
Ning S; Lyu M; Zhu D; Lam JWY; Huang Q; Zhang T; Tang BZ
ACS Nano; 2023 Jun; 17(11):10206-10217. PubMed ID: 37183977
[TBL] [Abstract][Full Text] [Related]
6. DNAzyme-Mediated Cascade Nanoreactor for Cuproptosis-Promoted Pancreatic Cancer Synergistic Therapy.
Yu Q; Zhou J; Liu Y; Li XQ; Li S; Zhou H; Kang B; Chen HY; Xu JJ
Adv Healthc Mater; 2023 Nov; 12(28):e2301429. PubMed ID: 37548109
[TBL] [Abstract][Full Text] [Related]
7. Stimulus-Responsive Copper Complex Nanoparticles Induce Cuproptosis for Augmented Cancer Immunotherapy.
Hu F; Huang J; Bing T; Mou W; Li D; Zhang H; Chen Y; Jin Q; Yu Y; Yang Z
Adv Sci (Weinh); 2024 Apr; 11(13):e2309388. PubMed ID: 38269649
[TBL] [Abstract][Full Text] [Related]
8. Inhalable metal-organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy.
Yan C; Liu Y; Zhao G; Yang H; Lv H; Li G; Li Y; Fu Y; Sun F; Feng Y; Li Y; Zhao Z
Acta Pharm Sin B; 2024 May; 14(5):2281-2297. PubMed ID: 38799628
[TBL] [Abstract][Full Text] [Related]
9. Microfluidic Synthesis of CuH Nanoparticles for Antitumor Therapy through Hydrogen-Enhanced Apoptosis and Cuproptosis.
He G; Pan Y; Zeng F; Qin S; Luan X; Lu Q; Xie C; Hu P; Gao Y; Yang J; He B; Song Y
ACS Nano; 2024 Mar; 18(12):9031-9042. PubMed ID: 38470458
[TBL] [Abstract][Full Text] [Related]
10. Photothermally Triggered Copper Payload Release for Cuproptosis-Promoted Cancer Synergistic Therapy.
Zhou J; Yu Q; Song J; Li S; Li XL; Kang BK; Chen HY; Xu JJ
Angew Chem Int Ed Engl; 2023 Mar; 62(12):e202213922. PubMed ID: 36585379
[TBL] [Abstract][Full Text] [Related]
11. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance.
Wang Y; Chen Y; Zhang J; Yang Y; Fleishman JS; Wang Y; Wang J; Chen J; Li Y; Wang H
Drug Resist Updat; 2024 Jan; 72():101018. PubMed ID: 37979442
[TBL] [Abstract][Full Text] [Related]
12. Biomimetic copper-doped polypyrrole nanoparticles induce glutamine metabolism inhibition to enhance breast cancer cuproptosis and immunotherapy.
Zhang N; Ping W; Rao K; Zhang Z; Huang R; Zhu D; Li G; Ning S
J Control Release; 2024 May; 371():204-215. PubMed ID: 38810704
[TBL] [Abstract][Full Text] [Related]
13. Copper Deposition in Polydopamine Nanostructure to Promote Cuproptosis by Catalytically Inhibiting Copper Exporters of Tumor Cells for Cancer Immunotherapy.
Chang J; Yin W; Zhi H; Chen S; Sun J; Zhao Y; Huang L; Xue L; Zhang X; Zhang T; Dong H; Li Y
Small; 2024 Feb; ():e2308565. PubMed ID: 38339770
[TBL] [Abstract][Full Text] [Related]
14. An Intelligent Cell-Derived Nanorobot Bridges Synergistic Crosstalk Between Sonodynamic Therapy and Cuproptosis to Promote Cancer Treatment.
Chen K; Zhou A; Zhou X; Liu Y; Xu Y; Ning X
Nano Lett; 2023 Apr; 23(7):3038-3047. PubMed ID: 36951267
[TBL] [Abstract][Full Text] [Related]
15. Targeted gene silencing in vivo by platelet membrane-coated metal-organic framework nanoparticles.
Zhuang J; Gong H; Zhou J; Zhang Q; Gao W; Fang RH; Zhang L
Sci Adv; 2020 Mar; 6(13):eaaz6108. PubMed ID: 32258408
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial-Targeted Copper Delivery for Cuproptosis-Based Synergistic Cancer Therapy.
Deng J; Zhuang H; Shao S; Zeng X; Xue P; Bai T; Wang X; Shangguan S; Chen Y; Yan S; Huang W
Adv Healthc Mater; 2024 Mar; ():e2304522. PubMed ID: 38530073
[TBL] [Abstract][Full Text] [Related]
17. Cuproptosis: mechanisms and links with cancers.
Xie J; Yang Y; Gao Y; He J
Mol Cancer; 2023 Mar; 22(1):46. PubMed ID: 36882769
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer.
Wang W; Lu K; Jiang X; Wei Q; Zhu L; Wang X; Jin H; Feng L
J Exp Clin Cancer Res; 2023 Jun; 42(1):142. PubMed ID: 37277863
[TBL] [Abstract][Full Text] [Related]
19. Cellular Trojan Horse initiates bimetallic Fe-Cu MOF-mediated synergistic cuproptosis and ferroptosis against malignancies.
Chen K; Zhou A; Zhou X; He J; Xu Y; Ning X
Sci Adv; 2024 Apr; 10(15):eadk3201. PubMed ID: 38598629
[TBL] [Abstract][Full Text] [Related]
20. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
